Navigation Links
Divigel(R) (estradiol gel) 0.1 Percent Offers Lowest Approved Dose of Estradiol for Treatment of Moderate to Severe Hot Flashes Associated with Menopause
Date:5/5/2008

ttack, blood clots, dementia, gallbladder disease and ovarian cancer.

In Divigel(R) clinical trials, the most common side effects were inflammation of the nasal passages and pharynx, upper respiratory tract infection, vaginal yeast infection, breast tenderness and vaginal bleeding. Call your healthcare provider right away if you have any symptoms that concern you.

Estrogen products should be used at the lowest dose possible for your treatment and only as long as needed. You and your healthcare provider should talk regularly about whether you still need treatment with Divigel(R).

For more information, including copies of the professional prescribing information and patient information leaflet with the black box and other warnings, call 1-800-654-2299 or visit http://www.divigelus.com.

Orion Corporation (OMX: ORNAV, ORNBV) has a licensing agreement with Upsher-Smith Laboratories for the development of Divigel(R) in the United States. Orion is one of the leading pharmaceutical companies in northern Europe through its development, manufacturing and marketing of pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The core therapeutic areas in Orion's product and research strategy are central nervous system disorders, cardiology, critical care and hormonal and urological therapies.

Upsher-Smith Laboratories, Inc. is a rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of our customers. Upsher-Smith prides itself in providing safe, effective, and economical therapies to the ever-challenged healthcare environment. For additional information about Upsher-Smith, visit http://www.upsher-smith.com.


'/>"/>
SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Data Reveal Topical Divigel(R) (estradiol gel) 0.1% Significantly Reduces Frequency and Severity of Hot Flashes
2. Phase II Study of Zevalin(R) Consolidation Following Fludarabine and Mitoxantrone Chemotherapy Results in 100 Percent Complete Remission Rate and 89 Percent Three-Year Progression Free Survival in Patients with Previously Untreated Non-Follicular Indolent
3. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
4. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
5. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Clinically Proven Treatment Offers Help to Rosacea Sufferers
8. Arizona Doctor Offers New Addiction Drug Treatment for Meth Addicts Showing More Than 60% Success Rate
9. St. Jude Study Offers New Hope for Children With Kidney Tumors Deemed Inoperable
10. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
11. American Laser Center Offers VelaShape Body Shaping and Cellulite Reduction Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 Vermillion, ... on gynecologic disease, announced today it will ... after the market close on Thursday, August ... call and webcast at 4:30pm Eastern.Conference Call ... at 4:30pm Eastern/1:30pm Pacific  Domestic: ...
(Date:7/30/2015)... 2015  NanoSmart Pharmaceuticals, Inc., a private pharmaceutical ... Orphan Drug Designation from the Food and Drug ... uses NanoSmart,s proprietary drug delivery platform. The drug ... treatment of Ewing,s sarcoma, a rare type of ... Drug Designation on the basis of a plausible ...
(Date:7/30/2015)... July 30, 2015 Flexpoint Ford, a private ... sectors, today announced that it has entered into a ... Stuart to form Kastle Therapeutics, LLC (Kastle).  The ... will focus on acquiring, developing and commercializing pharmaceuticals targeted ... opportunities include select therapies already approved for marketing, as ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
... Science is largely a collaborative enterprise. Frequently researchers ... pool their efforts and exchange ideas, to devise ... such as those known as autism spectrum disorders, ... on diverse populations of patients, finding a broader ...
... Evaluate Whether Olmesartan Medoxomil Prevents Onset of Early Kidney Disease ... Blinded one-year blood pressure (BP) reduction data from the ongoing ... lmesartan A nd D iabetes M icro ... American Society of Hypertension (ASH) Twenty-Fourth Annual Scientific Meeting and ...
Cached Medicine Technology:Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 2Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 3Autism Studies Presented at Mid-Atlantic Research Consortium Meeting 4Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 2Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 3Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 4Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 5Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 6Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results 7
(Date:7/30/2015)... (PRWEB) , ... July 30, ... ... released a video, “Beachside Nursing Center,” to announce its position as one ... ratings. Beachside's administrator and staff members support the CMS rating system, which ...
(Date:7/30/2015)... Plainsboro, NJ (PRWEB) , ... July 30, 2015 ... ... partners continues to expand, as the company and UCLA’s Jonsson Comprehensive Cancer ... research, OncLive announced today. With the new collaboration, OncLive’s editorial and marketing groups ...
(Date:7/30/2015)... ... 30, 2015 , ... The Mesothelioma Applied Research Foundation (Meso ... Act of 2015’. The bill was introduced in Congress yesterday by Representatives John ... (D-MN), Joe Kennedy (D-MA), and Leonard Lance (R-NJ). The purpose of the bill ...
(Date:7/30/2015)... ... July 30, 2015 , ... Western University of Health Sciences faculty, students and ... Games, the largest sports and humanitarian event in the world this year and the ... Games, held July 25 through August 2, 2015, benefited from the participation of WesternU’s ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Between 2012 ... to the Health News Florida on June 17th. Those untreated heroin use ... programs to prevent the spread of dirty needles throughout the community. Ultimately Florida’s HIV ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 2Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 3Health News:UCLA Jonsson Comprehensive Cancer Center Teams with OncLive® as a Strategic Alliance Partner 4Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3
... Child Deserves The Opportunity To Smile.PACIFIC PALISADES, Calif., April ... every child,s life is the opportunity to smile. BrittiCares ... just that. BrittiCares (BCI) will hold its 4th annual ... Pacific Palisades High School. Hosted by Chris Tucker, the ...
... Alliance Announces Eight New Associate Members to Help Raise ... Eight medical groups, public health associations and obesity ... O vercome and P revent (STOP) Obesity ... and private sector decision makers grappling with the high ...
... Elsevier, the world-leading publisher of scientific, technical ... to announce the launch of a new journal, ... infectious disease dynamics ( http://www.elsevier.com/locate/epidemics ). , ... disease dynamics in the broadest sense. Its scope ...
... Gold Standard Status for Bipolar Depression, According to ... 27 Decision Resources, one of the world,s ... healthcare issues, finds that surveyed psychiatrists identify a ... symptoms as the attribute that most influences their ...
... Senior Living, Inc. (OTC Bulletin Board: TCSR), which develops, ... the expansion of its presence on radio in coordination ... talk radio program heard daily on over 265 radio ... a large and growing national audience, and we are ...
... is largely underpenetrated, according to Millennium Research GroupWALTHAM, ... Group,s (MRG,s) Opportunities in Brazil ... Market 2009 report, Brazil is extremely underpenetrated ... devices. The varicose vein treatment device market in ...
Cached Medicine News:Health News:BrittiCares International 'Smile For Life' 5K Run/Walk Gears Up to Save Lives 2Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 2Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 3Health News:As Health Reform Takes Shape, Leading Medical and Public Health Organizations Join Effort to Keep Obesity Front and Center 4Health News:Elsevier launches Epidemics -- the journal on infectious disease dynamics 2Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 2Health News:For Bipolar Depression, Surveyed Experts Indicate That Current and Emerging Therapies Have No Advantage Over Seroquel in Decreasing the Severity of Symptoms 3Health News:National Radio Program to Expand Awareness of TrinityCare's Unique Approach to Senior Adult Care 2Health News:National Radio Program to Expand Awareness of TrinityCare's Unique Approach to Senior Adult Care 3Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 2Health News:Growth Opportunity in Brazil's Varicose Vein Treatment Device Market 3
1.5 mm x 12 mm tip. Angled 15 degrees. Teflon coated with diathermy attachment....
2 mm diameter blade. Angled 60 degrees. Sharp. Round handle....
2 mm. Angled 13 degrees, 15 mm from angle to tip. Round handle....
1.25 mm x 2.5 mm blade. 135 degrees back scratcher. Round handle....
Medicine Products: